🚀 VC round data is live in beta, check it out!
Lunit Valuation Multiples
Discover revenue and EBITDA valuation multiples for Lunit and similar public comparables like Yidu Tech, Diagnósticos da América, Castle Biosciences, Equasens and more.
Lunit Overview
About Lunit
Lunit Inc is a medical AI software company devoted to providing AI-powered total cancer care. Its products comprise of Lunit INSIGHT CXR, AI solution for Chest x-ray; Lunit INSIGHT MMG, AI solution for Mammography; Lunit SCOPE IO, AI-Powered Biomarker for Immuno-Oncology; and Lunit SCOPE PD-L1, AI Solution for PD-L1 Expression.
Founded
2013
HQ
Employees
312
Website
Financials (FY)
EV
$849M
Lunit Financials
Lunit reported last fiscal year revenue of $57M and negative EBITDA of ($7M).
In the same fiscal year, Lunit generated $57M in gross profit, ($7M) in EBITDA losses, and had net loss of ($32M).
Revenue (LTM)
Lunit P&L
In the most recent fiscal year, Lunit reported revenue of $57M and EBITDA of ($7M).
Lunit expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | — | XXX | $57M | XXX | XXX | XXX |
| Gross Profit | — | XXX | $57M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 100% | XXX | XXX | XXX |
| EBITDA | — | XXX | ($7M) | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | (13%) | XXX | XXX | XXX |
| EBIT Margin | — | XXX | (100%) | XXX | XXX | XXX |
| Net Profit | — | XXX | ($32M) | XXX | XXX | XXX |
| Net Margin | — | XXX | (57%) | XXX | XXX | XXX |
| Net Debt | — | — | $54M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Lunit Stock Performance
Lunit has current market cap of $787M, and enterprise value of $849M.
Market Cap Evolution
Lunit's stock price is $25.20.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $849M | $787M | 0.0% | XXX | XXX | XXX | $-1.04 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialLunit Valuation Multiples
Lunit trades at 15.0x EV/Revenue multiple, and (115.0x) EV/EBITDA.
EV / Revenue (LTM)
Lunit Financial Valuation Multiples
As of April 19, 2026, Lunit has market cap of $787M and EV of $849M.
Equity research analysts estimate Lunit's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Lunit has a P/E ratio of (24.4x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $787M | XXX | $787M | XXX | XXX | XXX |
| EV (current) | $849M | XXX | $849M | XXX | XXX | XXX |
| EV/Revenue | — | XXX | 15.0x | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | (115.0x) | XXX | XXX | XXX |
| EV/EBIT | — | XXX | (15.0x) | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 15.0x | XXX | XXX | XXX |
| P/E | — | XXX | (24.4x) | XXX | XXX | XXX |
| EV/FCF | — | XXX | (19.2x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Lunit Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Lunit Margins & Growth Rates
Lunit's revenue in the last fiscal year grew by 53%.
Lunit's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.4M for the same period.
Lunit Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | — | XXX | 53% | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | (13%) | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | (83%) | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.2M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.4M | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 24% | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 7% | XXX | XXX | XXX |
| R&D Expenses to Revenue | — | XXX | 50% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 200% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Lunit Public Comps
See public comps and valuation multiples for other Medical Imaging & Diagnostics and Healthcare Software comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Lunit | XXX | XXX | XXX | XXX | XXX | XXX |
| Yidu Tech | XXX | XXX | XXX | XXX | XXX | XXX |
| Diagnósticos da América | XXX | XXX | XXX | XXX | XXX | XXX |
| Castle Biosciences | XXX | XXX | XXX | XXX | XXX | XXX |
| Equasens | XXX | XXX | XXX | XXX | XXX | XXX |
| PHC Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Lunit M&A Activity
Lunit acquired XXX companies to date.
Last acquisition by Lunit was on XXXXXXXX, XXXXX. Lunit acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Lunit
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialLunit Investment Activity
Lunit invested in XXX companies to date.
Lunit made its latest investment on XXXXXXXX, XXXXX. Lunit invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Lunit
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Lunit
| When was Lunit founded? | Lunit was founded in 2013. |
| Where is Lunit headquartered? | Lunit is headquartered in South Korea. |
| How many employees does Lunit have? | As of today, Lunit has over 312 employees. |
| Who is the CEO of Lunit? | Lunit's CEO is Beom-Seok Seo. |
| Is Lunit publicly listed? | Yes, Lunit is a public company listed on Korea Exchange. |
| What is the stock symbol of Lunit? | Lunit trades under 328130 ticker. |
| When did Lunit go public? | Lunit went public in 2022. |
| Who are competitors of Lunit? | Lunit main competitors are Yidu Tech, Diagnósticos da América, Castle Biosciences, Equasens. |
| What is the current market cap of Lunit? | Lunit's current market cap is $787M. |
| What is the current revenue of Lunit? | Lunit's last fiscal year revenue is $57M. |
| What is the current EV/Revenue multiple of Lunit? | Current revenue multiple of Lunit is 15.0x. |
| Is Lunit profitable? | No, Lunit is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.